Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

Cancer

Volumn 118, Issue 22, 2012, Pages 5595-5600

  Scott, Jacob G ^a   Bauchet, Luc ^b   Fraum, Tyler J ^c,d   Nayak, Lakshmi ^e   Cooper, Anna R ^f   Chao, Samuel T ^g   Suh, John H ^g   Vogelbaum, Michael A ^g   Peereboom, David M ^g   Zouaoui, Sonia ^b   Mathieu Daudé, Hélène ^h   Fabbro Peray, Pascale ^i,j   Rigau, Valérie ^k   Taillandier, Luc ^l   Abrey, Lauren E ^e   Deangelis, Lisa M ^e   Shih, Joanna H ^c   Iwamoto, Fabio M ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h CENTRE VAL D AURELLE   (France)

ⁱ UNIV MONTPELLIER   (France)

^j NÎMES UNIVERSITY HOSPITAL   (France)

^k GUI DE CHAULIAC HOSPITAL   (France)

^l Hopital Neurologique   (France)

more..

Author keywords

aging; elderly; glioblastoma; prognosis; surgery

Indexed keywords

AGED; ANALYTIC METHOD; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURSIVE PARTITIONING ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 84868122254     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27570     Document Type: Article

References (21)

1. Wen PY, Kesari S,. Malignant gliomas in adults. N Engl J Med. 2008; 359: 492-507.
2. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL,. Epidemiology of brain tumors. Neurol Clin. 2007; 25: 867-890.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS,. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002; 4: 278-299.
4. Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res. 2004; 10 (1 Pt 1): 228-233.
5. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H,. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009; 15: 6002-6007.
6. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993; 85: 704-710.
7. Lamborn KR, Chang SM, Prados MD,. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004; 6: 227-235.
8. Ciampi A, Lawless JF, McKinney SM, Singhal K,. Regression and recursive partition strategies in the analysis of medical survival data. J Clin Epidemiol. 1988; 41: 737-748.
9. Paravati AJ, Heron DE, Landsittel D, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. J Neurooncol. 2011; 104: 339-349.
10. Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE,. Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). Cancer. 2009; 115: 3758-3766.
11. Scott JG, Suh JH, Elson P, et al. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol. 2011; 13: 428-436.
12. Bauchet L, Mathieu-Daude H, Fabbro-Peray P, et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol. 2010; 12: 725-735.
13. Kelly PJ, Hunt C,. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994; 34: 62-66.
14. Vuorinen V, Hinkka S, Färkkilä M, Jä äskeläinen J,. Debulking or biopsy of malignant glioma in elderly people-a randomised study. Acta Neurochir (Wien). 2003; 145: 5-10.
15. Laigle-Donadey F, Delattre JY,. Glioma in the elderly. Curr Opin Oncol. 2006; 18: 644-647.
16. Sanai N, Berger MS,. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008; 62: 753-764.
17. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE,. Patterns of care in elderly glioblastoma patients. Ann Neurol. 2008; 64: 628-634.
18. Barnholtz-Sloan JS, Williams VL, Maldonado JL, et al. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg. 2008; 108: 642-648.
19. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007; 356: 1527-1535.
20. Scott J, Tsai YY, Chinnaiyan P, Yu HH,. Effectiveness of radiotherapy for elderly patients with glioblastoma. Int J Radiat Oncol. 2011; 81: 206-210.
21. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352: 997-1003.